The Company's Annual General Shareholders' Meeting
approved the removal of non-competition restrictions on
Directors
Date of events
2022/06/24
To which item it meets
paragraph 21
Statement
1.Date of the shareholders' meeting resolution:2022/06/24
2.Name and title of the managerial officer with permission
to engage in competitive conduct:
Feng-Lin Kou, Director
Po-Hsiung Kuo, Director
Yi-Fan Yu, Director
Chui-Chin Lin, Director
Yu-Shan Lu, Independent Director
Che-Chen Wei, Independent Director
Hsin-Yu Chung, Independent Director
3.Items of competitive conduct in which the officer is
permitted to engage:
Those which are not detrimental to the Company's benefit.
4.Period of permission to engage in the competitive conduct:During the
tenure of the aforementioned Directors.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):Under Article 209 of the
Company Act,the Company's Annual General Shareholders' Meeting on
2022/06/24 approved to remove the non-competition restrictions on
the aforementioned Directors, provided that such act is not
detrimental to the Company's benefit.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter "N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:none
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:N/A
12.Any other matters that need to be specified:none
Attachments
Original Link
Original Document
Permalink
Disclaimer
EPS Bio Technology Corporation published this content on 24 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 June 2022 07:05:00 UTC.
EPS Bio Technology Corp. is a Taiwan-based company principally engaged in the manufacture and sales of medical test strips and equipment. The Company's main products include blood glucose testers, blood glucose test strips and electric breast pumps. The Company distributes its products mainly to overseas markets, such as Europe, North America and the rest areas of Asia.
EPS BIO TECHNOLOGY CORP. 
